Drug Approval Process

My tests had several questions that referenced to the drug approval process. I suggest that anyone planning to take the MPJE for any state be familiar with the drug approval processes

Investigational New Drug Application

•1stapplication before drug is given to humans

•Federal Drug Administration (FDA) has 30 days to decide if suitable for testing

•Must provide clinical protocols to be used in human testing

Clinical Trials

Initiated after FDA approves the investigational new drug application

3 phases before marketing and 1 phase after marketing

Phase 1: Small group of healthy individuals to evaluate toxicity, kinetics, safety

Phase 2: Large group (100+) with the disease being treated to evaluate effectiveness, safety, and adverse drug events (ADEs)

Phase 3: Large group (1000+) to evaluate effectiveness, double-blinded with placebo

Phase 4: Post-marketing surveillance to determine if drug should stay on the market

New Drug Application (NDA)

Can apply once data on safety, efficacy, toxicity, stability, production methods, packaging and clinical trial data exists

Typically takes 6 months for review 

Abbreviated New Drug Application (ANDA)

For introducing a generic of an already approved drug

Requires proof of kinetics, bioequivalence/bioavailability

Supplemental New Drug Application (SNDA)

For changes to synthesis, production, manufacturer location, packaging and/or labeling

For new dose form, strength or therapeutic use

Epidiolex – What is it? Is it a controlled substance?

What is it?

First and only FDA-approved prescription cannabidiol (CBD)

What is it used for?

Seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome or tuberous sclerosis complex (TSC)

Mechanism of action for the reduction of seizures is unknown.

How is it dosed and taken?

Titrated dosing given orally or via feeding tube (non PVC) twice daily, administered consistently with or without food.

LGS or Dravet syndrome:

Initial dose: 5mg/kg/day (2.5mg/kg twice daily)

Recommended dosing: 10 to 15mg/kg/day (5 to 7.5mg/kg twice daily) increased in weekly increments of 5mg/kg/day (2.5mg/kg twice daily)

Maximum dosing: 20mg/kg/day (10mg/kg twice daily) 

TSC:

Initial dose: 5mg/kg/day (2.5mg/kg twice daily)

Recommended dosing: 10 to 20mg/kg/day (5 to 10mg/kg twice daily) increased in weekly increments of 5mg/kg/day (2.5mg/kg twice daily)

Maximum dosing: 25mg/kg/day (12.5mg/kg twice daily) 

If rapid titration is necessary, dose may be increased no more frequently than every other day.
Dose adjustment and a slower titration is recommended in patients with moderate to severe hepatic impairment.
Should not be stopped suddenly due to the risk of increased frequency of seizures and status epilepticus. 

Recommended lab work: 

Transaminase and bilirubin levels prior to starting treatment, at month 1, month 3 and month 6 then periodically thereafter.

Patients on valproate or are at increased risk of elevated transaminase levels and/or hepatocellular injury.  

If levels are elevated, consider a dose reduction or discontinuation of Epidiolex or other medications known to increase transaminase levels such as valproate and/or clobazam.  

Common side effects (> 10% and greater than placebo): transaminase elevations, somnolence, fatigue, malaise, asthenia, decreased appetite, diarrhea, vomiting, pyrexia, rash, insomnia and infections.

Other important side effects to be aware of: suicidal behavior and ideation

Potential interactions to consider:

Several potential drug-drug interactions to consider, most commonly run into potential drug-drug interactions with other anticonvulsant medications:

Clobazam, diazepam, & valproate

Recommended to counsel patient or caregiver on signs/symptoms to watch for and recommend lab work as appropriate.  

Strawberry flavored but does not contain strawberry.

Compatible with a ketogenic diet.

Federal law no longer considers Epidiolex to be a controlled substance.  It had originally been federally scheduled as a CV.  Now it is federally non-controlled.  There are a handful of states that have it scheduled as a controlled substance.  

https://www.drugtopics.com/view/dea-deschedules-antiepileptic-cbd-oral-solution-epidiolex

Controlled StatusState
CIVLouisiana
CVFlorida
CVGeorgia
CVIdaho
CVMaryland
CVMontana
CVNebraska
CVNorth Dakota
CVPuerto Rico
Controlled Substance Status of Epidiolex (all other states are non-controlled)

Other State Specific Controlled Substance Topics

It’s a great idea to consider some other state specific controlled substance regulations.  Some of these may be:

State Controlled Substance Monitoring Program

Not all states, however most states have a controlled substance monitoring program that allows prescribers and pharmacists to evaluate a patient’s prescription drug history.  Each state can specify what information is reportable, how soon after dispensing it must be reported, how it is reviewed and documented, which medications are included, specific exemptions and how long records must be kept.  Some states also require a zero report be filed even if a pharmacy does not dispense controlled substances.

State Specific Controlled Substances

Some states designate a medication as a controlled substance or a stricter class of controlled substance even if federal law does not.  Some examples of medications to look at for this are: growth hormone, HCG, testosterone, Epidiolex (cannabidiol), Neurontin (gabapentin), Ultam (tramadol), butalbital containing products, Donnatol (phenobarbital and belladonna alkaloids), Librax (chlordiazepoxide and clinidium), ephedrine, pseudoephedrine, Soma (carisoprodol), etc.

Mid-Level Practitioners Prescribing Authority

Prescriber authority for mid-level practitioners such as nurse practitioners or physician assistants can vary state to state.  Some are limited as to what controls they may prescribe, day supply allowed, what setting they may prescribe in, etc. The button below is a link to the DEA website that provides a listing by state.

Naloxone

Some states allow pharmacists to dispense Naloxone without a prescription under a collaborative practice agreement, statewide protocol or standing order.  There are different limitations and documentation required state to state.

Controlled Substances CIII-CV

When taking the exam it’s important to read each question carefully and concentrate on which law, general concept or principle the question is testing.

When a drug name is given in a question, identify if it is OTC, prescription only or a controlled substance. Then, use that information to determine which laws apply and how they apply to the question at hand.

Always remember, state law may be stricter and if so STATE LAW APPLIES.

CIII Medications

Drugs with Moderate to Low Potential for Physical and Psychological Dependence

Combination products containing less than 90mg of codeine per dosage unit (Tylenol with codeine)

Fiorinal is CIII however Fioricet is non-controlled

  Fiorinal: ASA 325mg/butalbital 50mg/caffeine 40mg

  Fioricet: APAP 325mg/butalbital 50mg/caffeine 40mg

buprenorphine (Suboxone)benzphetamine (Didrex)
ketaminephendimetrazine
anabolic steroidsThiopental
testosteroneFiorinal
CIII medications

CIV Medications

Drugs with Low Potential for Abuse or Dependence
alprazolam (Xanax)diazepam (Valium)
carisoprodol (Soma)lorazepam (Ativan)
clonazepam (Klonopin)midazolam (Versed)
clorazepate (Tranxene)temazepam (Restoril)
triazolam (Halcion)phenobarbital
butorphanol
CIV Medications

CV Medications

Drugs with Lower Potential for Abuse 

Preparations containing limited quantities of certain narcotics

Generally used for antidiarrheals, antitussives, and analgesic purposes

Examples: Cough preparations with ≤ 200mg of codeine per 100mL or 100g (Robitussin AC, Phenergan with Codeine), Lomotil, Lyrica

CIII-CV Valid Types of Prescriptions

Written signed prescription

Fax of written prescription

Erx

Verbal

Containing all information except prescriber signature

Transfer

ONE TIME for the purpose of REFILL dispensing

Pharmacies electronically sharing a real-time system may transfer up to max refills permitted by law and prescription

CIII-CIV Refills (and CV in Most States)

No more than 5 refills within a 6 month period

Must keep information on the back of the original prescription or in a computerized record-keeping system

Must be accessible within 48 hours

Must record: Prescriber name, Name and address of the patient, Quantity dispensed on each refill, Date of dispensing for each refill, Name or ID code of the dispensing pharmacist and Number of the original prescription order

CIII-CV Partial Filling

Partial filling is allowed

Each partial should be recorded in the same manner as a refill

The total quantity dispensed in all partial fillings cannot exceed the total quantity prescribed

No dispensing may occur beyond 6 months after the date Rx was written

Filling a CV Without a Prescription/Limitations

Only a pharmacist may dispense an over the counter CV

A non-pharmacist may complete the money transfer at the register

Purchaser must be ≥ 18 years old (Rph can require proof of age)

Furnish identification 

Bound record book must be maintained by the pharmacist: Name and address of the purchaser, Name and quantity of the CV purchased, Date of purchase, Name or initials of pharmacist that dispensed, Records must be kept for 2 years

Not more than _______ in a 48 hourperiod to the same purchaser

240mL (8 ounces) of any controlled substance containing opium

48 dosage units of any such controlled substance containing opium

120mL (4 ounces) of any other controlled substance

24 dosage units of any other controlled substance

Therefore, MAX is 4 fluid ounces of codeine containing cough syrup over the counter to a given purchaser in a 48 hour period.

Check out the detailed information in our guided course and downloadable study guides on Teachable.

Controlled Substances CII

When taking the exam it’s important to read each question carefully and concentrate on which law, general concept or principle the question is testing.  

When a drug name is given in the question identify if it is OTC, prescription only or a controlled substance. Use that information to determine which laws apply and how they apply to the question at hand.

Always remember, state law may be stricter and if so STATE LAW APPLIES.

Drugs with a high potential for abuse
Potential to lead to severe psychological or physical dependence
Dangerous
hydromorphone (Dilaudid) fentanyl (Sublimaze, Duragesic)hydrocodoneamobarbital
methadone (Dolophine)morphineamphetamine (Dexedrine, Adderall)glutethimide
meperidine (Demerol)opiummethamphetamine (Desoxyn)pentobarbital 
oxycodone (OxyContin, Percocetcodeinemethylphenidate (Ritalin)secobarbital
CII Controlled Substances

Barbiturates

Amobarbital (Amytal), pentobarbital (Nembutal) and secobarbital (Seconal) are CIIs.

Phenobarbital (Luminal) is a CIV.

Hydrocodone

Hydrocodone was reclassified to CII in 2014.

CII Prescription Requirements: Valid Types of Prescriptions

Written signed prescription

Erx

Oral (ONLY in emergency)

Fax (ONLY if home infusion, long term care facility, hospice)

CII Prescriptions: What Can be Changed?

Patient address (can also obtain from patient)

Drug strength

Dosage form

Drug quantity

Directions

CII Prescriptions: What Cannot be Changed?

Patient’s Name

Controlled substance prescribed

Prescriber’s Signature

⬆️ Any of the above items would require a new prescription.

CII Prescriptions: Partial Filling

No refills are allowed on CII prescriptions

Partial may be dispensed: 

*If it is not prohibited by State laws*

The partial fill is requested by the patient or the practitioner who wrote the prescription.

The total quantity dispensed in all partial fillings does not exceed the total quantity prescribed.

Within 30 days of the date on which the prescription was written 

Exception: Terminal patients may get a partial dispense and prescription is void 60 days after written

Partial dispense prescription documentation:

Date of partial fill

Quantity dispensed

Remaining quantity

Dispensing pharmacist

Check out the detailed information in our guided course and downloadable study guides on Teachable!!

Career Advancement: What Options do Pharmacists Have?

I used to be intimidated at the thought of committing to career advancement.  I felt overwhelmed by the options available.  I didn’t know where to start, what interested me or where I should direct my time and energy.  I was afraid of the potential time commitment and navigating the application processes. 

 I took my first steps into career advancement by signing up to obtain additional state pharmacist licenses.  The process was easier and smoother than I had expected it to be.  I thought it would be difficult to study and prepare while working full time and taking care of family commitments.  I carved out time to study around our family commitments in the late evening, early morning and even during my kid’s activities (ALL the sports practices!).  

There are so many options to consider!  There are certificate programs, board specialties, licenses, and other educational opportunities.  Any pharmacist can find their niche for career advancement.  I recommend making sure any certification or specialization is being offered through a reputable organization.  ASHP and APhA offer certificate programs. There are websites dedicated to the board specialties. Other educational opportunities may be found through online colleges or local colleges. I have included links below.

Certification Programs to consider:

Pain Management

Pediatrics

Diabetes Management

Medication Reconciliation 

Pharmacy Revenue Cycle Management

Pharmacokinetics

Medication Safety

Emergency Medicine

Nutrition Support

Sterile Compounding

Sterile Product Preparation Institutional Training

Informatics

Pharmacogenomics

Teaching

Veterinary Medicine

Apexus Advanced 340B Operations

Anticoagulation

Crisis and Pandemic Management

Well-being and Resilience

Diversity, Equity and Inclusion

Board Specialties to consider:

Ambulatory Care Pharmacy

Cardiology Pharmacy

Compounded Sterile Preparations Pharmacy

Critical Care Pharmacy

Geriatric Pharmacy

Infectious Diseases Pharmacy

Nuclear Pharmacy

Nutrition Support Pharmacy

Oncology Pharmacy

Pediatric Pharmacy

Pharmacotherapy

Psychiatric Pharmacy

Solid Organ Transplant Pharmacy

Specialty Pharmacy

Niche Opportunities:

Bioidentical Hormones

Immunizations

Weight Management

Smoking Cessation

Healthy Seniors Programs

Other Opportunities:

Pharmacy Leadership Academy

Lean Six Sigma

Leadership and Management Courses through online colleges or local colleges

Look for your dream job online, then review that position’s list of required and preferred qualifications, skills, abilities and requirements. This can be a great starting place to find out what you need to do to get where you want to be.

Lastly, I don’t want to downplay the power of networking. It can be VITAL, especially if you wish to find a position at a new company or in a different industry.

DEA Form 106: Theft or Loss of Controlled Substances

Discovering a Theft of Controlled Substances

Must contact the nearest DEA Diversion Field Office upon discovery

Notify local police

Complete DEA Form 106 Report of Theft or Loss of Controlled Substances 

If review shows no actual controlled substance loss, then Form 106 is not needed.  Inform DEA in writing to close the initial report. 

Link to PDF of DEA Form 106: https://www.deadiversion.usdoj.gov/21cfr_reports/theft/DEA_Form_106.pdf

Federal Investigation of Pharmaceutical Theft or Robbery

A Federal Investigation occurs if any one or more of the following:

Replacement cost of controlled substances is ≥ $500

Someone is killed or suffers significant injury

Interstate or foreign commerce is involved in planning or executing the crime  

In-transit Loss

If an in-transit loss occurs, the supplier is responsible for reporting the loss.  

The pharmacy is only responsible after signing for the shipment.

Pharmacy Employment Practices

Pharmacy must not employ anyone with a controlled substance felony on record or anyone who has had a DEA registration denied, revoked or suspended.

A waiver may be approved in certain situations but will only be considered for approval if diversion is unlikely to occur.

DEA Form 41: Destruction of Controlled Substances

Two Methods:

1. Request DEA authorization to destroy damaged, outdated, and/or unwanted controlled substances 

Once per calendar year for retail pharmacies through the nearest DEA Division Field Office

Complete DEA Form 41 (Registrant’s Inventory of Drugs Surrendered)

Write a letter to the DEA to request permission to destroy, including: date and method of destruction, names of 2 people who will be witnesses (physician, pharmacist, physician assistant, nurse practitioner, nurse or law enforcement officer)

Send letter and DEA Form 41 at least 2 weeks prior to proposed destruction date and await written decision

Once destroyed, signed and completed copies of DEA Form 41 must be forwarded to the DEA

Exception to prior authorization: If a member of a state law enforcement authority or regulatory agency witnesses the destruction, then prior authorization from the nearest DEA Diversion Field Office or local DEA Special Agent in Charge is not required

Copies of a DEA Form 41 or state controlled substance destruction form must be forwarded to the local DEA Diversion Field Office after the destruction

2. Forward controlled substances to a DEA registered distributor who handles the disposal of drugs

Can be done at anytime

Local DEA Division Field Office can provide an updated list of distributors

The distributor must issue a DEA Form 222 to the pharmacy if CII medications are included

For CIII-CV, the pharmacy should document drug name, dose form, strength, quantity and date transferred in writing 

The DEA registered distributor who will destroy the controlled substances is then responsible for submitting DEA Form 41 to the local DEA Diversion Office

Hospital/Institution Pharmacy Controlled Substances

Must keep records of dispensing, destruction, disposal including:

Patient name with date of birth or medical record number as second identifier

Drug name, dose and dose form

Prescriber

Name of individual that dispenses

Name of individual that administers

Date and time of administration

Name of witness observing disposal of unused drug 

“Blanket Authorization”

Issued on a very limited basis for registrants associated with hospitals, clinics or others needing to dispose of used needles, syringes and other injectable objects only

Granted due to the contamination by hazardous body fluids

Requests for ”blanket authorization” are based on: 

Frequency of destruction and volume involved

Method of destruction – must be incinerated or other method involving complete destruction

Registrant’s history 

Security at the pharmacy or registered location

Name and title of the person responsible for destruction

Must still complete a DEA Form 41

Source: deadiversion.usdoj.gov

Link to DEA Form 41: https://www.deadiversion.usdoj.gov/21cfr_reports/surrend/41_form.pdf

DEA 222 Forms: Triplicate, Single-Form, CSOS, Returns and Transfers

DEA 222 Triplicate Forms

Used to purchase, transfer or return schedule I and II medications

Can be signed by the individual authorized on the application for registration or anyone else with power of attorney

Have original, duplicate and triplicate carbon sheets

Copy #ColorWhere does it go?
1BrownSupplier
2GreenTo supplier then to DEA
3BlueKept by purchaser
Triplicate Form Copies and Records

Each different product must be on a separate line! 

Link to example of filling out DEA 222 triplicate form: https://northamerica.covetrus.com/docs/default-source/regulatory-documents/222-checlist-v16.pdf?sfvrsn=e8e26e73_2

An order may be partially filled within 60 days (expires at 60 days).

Purchaser notes the quantity recieved and date on Blue Copy 3 when receiving their order.

For Federal DEA purposes these records need to be kept for 2 years (some states may require longer).

Any unused forms must be returned to the DEA.

Lost or stolen forms should be reported to the Special Agent in Charge of the DEA in the Divisional office responsible for the area.

For reverse distributors, using the triplicate form process, pharmacy would receive Copy 1 and Copy 2 of the triplicate form, keeping Copy 1 and mailing Copy 2 to the local DEA office. 

DEA Legal Amendment to Update to a Single-Sheet Format for DEA 222

SUMMARY: The Drug Enforcement Administration (DEA) is amending its regulations to implement a new single-sheet format for DEA Form 222, used by DEA registrants to order schedules I and II controlled substances. The rule provides for a two-year transition period, during which the existing triplicate version of the forms may continue to be used. The rule also includes a number of minor procedural changes.

DATES: This rule is effective October 30, 2019.

Link to the detailed DEA Single-Sheet Format document: https://www.deadiversion.usdoj.gov/fed_regs/rules/2019/fr0930.htm

Any triplicate forms on hand may be used until October 30, 2021.  

Once triplicate forms on hand have been used, the DEA will begin sending single sheet DEA 222 Forms instead of the triplicate forms.  

If any triplicate forms are still on hand on October 30, 2021, they should be sent into the Registration Section at DEA Headquarters and the single-sheet form should begin being used.  

Since there is no longer a triplicate portion to keep at the pharmacy, the pharmacy will need to make a copy of the new single-sheet DEA 222 form either as a hard copy or electronic copy.  Pharmacy will still need to document the quantity received and the date received at the pharmacy. 

For Federal DEA purposes these records need to be kept for 2 years (some states may require longer).   

The DEA 222 process has also been updated for reverse distributors.  With the triplicate form process, pharmacy would receive Copy 1 and Copy 2 of the triplicate form, keeping Copy 1 and mailing Copy 2 to the local DEA office.  With the single-sheet DEA 222 Form, pharmacy will receive the single copy, then make a copy and send it to the local DEA office.  It is still required to document the quantity shipped and date shipped on the order form.

CSOS: Controlled Substance Ordering System

CSOS is the computerized system used for ordering controlled substances. 

CSOS orders can include scheduled I-V and non-controlled.

If CSOS is down or the CSOS account is closed, then a paper form will be required to order.  

Ordering overview diagram
Source: DEA website

1. An individual enrolls with DEA and, once approved, is issued a personal CSOS Certificate.

2. The purchaser creates an electronic 222 order using an approved ordering software. The order is digitally signed using the purchaser’s personal CSOS Certificate and then transmitted to the suppliers. The paper 222 is not required for electronic ordering.

3. The supplier receives the purchase order and verifies that the purchaser’s certificate is valid with DEA. Additionally, the supplier validates the electronic order information just like it would a paper order.

4. The supplier completes the order and ships to the purchaser. Any communications regarding the order are sent electronically.

5. The order is reported by the supplier to DEA within two business days

Above graphic and list is provided from the DEAecom.gov website.

Link to CSOS overview: https://www.deaecom.gov/overview.pdf

Distribution of Controlled Substances

Distribution shall be recorded by distributing and receiving pharmacies or practitioners. Receipts are to include: the controlled substance name, dosage form, dosage units in each container and number of containers ordered and received for record keeping.

If the controlled substance is a Schedule I or II, a DEA 222 must be used for the transaction.

Total number distributed during the calendar year shall not exceed 5% of the total number of all controlled substances during the same calendar year.

If number distributed will exceed 5% must obtain a registration to distribute controlled substances (i.e., wholesaler’s permit).

A PRESCRIBER MAY NOT WRITE A PRESCRIPTION FOR “OFFICE USE”.

Next week we will review DEA Form 41.

DEA Registration Applications: What should a Pharmacist know for the MPJE?

Part 1 of our deep dive into DEA Applications and Forms

What is the DEA?

Drug Enforcement Administration

Part of the United States Department of Justice

Responsible for the Controlled Substances Act

Those authorized to possess controlled substances must be registered by the DEA. 

Each location that manufacturers, distributes or dispenses controlled substances must have its own DEA registration.

Pharmacists usually do not need to register as an individual with the DEA if they are working in a registered location.  

Form 224Application for Pharmacy registration
Form 224aRenewal for Pharmacy registration
Form 225Application for Manufacturer or Researcher registration
Form 225aRenewal for Manufacturer or Researcher registration
Table of DEA Application Forms

Examples of applications can be found at:

https://www.deadiversion.usdoj.gov/drugreg/reg_apps/index.html

All locations that manufacturer, distribute or dispense controlled substances must register with the DEA with the exception of:

  1. Warehouses used for storage of controlled substance by registrants
  2. A prescriber’s office where controlled substances are prescribed – not administered or dispensed.
  3. Freight delivery companies
  4. A location where sales of controlled substances are made, solicited or supervised, but the location does not actually keep controlled substances on site

DEA registrations are valid for 36 months.

Renewal forms are sent to the registrant 60 days before the current registration expires.

Registrant must contact the DEA in writing if they do not receive their renewal forms within 45 days before the current registration expires.

The DEA may deny or revoke a registration if:

  1. Information on the application is untrue
  2. Applicant has been convicted of a drug-related felony
  3. Registration would be inconsistent with the public interest
  4. State license has been suspended, revoked or denied

May also revoke license if applicant is excluded from Medicare or state health program participation

Federal law does NOT require the applicant for DEA registration to be a pharmacist. 

Hospital registrations are treated as an “institutional practitioner” and DEA registration is issued to the entire hospital.

Power of Attorney

An applicant may authorize another individual or individuals to sign official forms by filing with the Registration Unit of the DEA, a Power of Attorney for each authorized individual. It remains valid until revoked with a Notice of Revocation.

Source: deadiversion.usdoj.gov

Next weeks deep dive will review DEA Form 222.